Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiometabolic Disease, Substrate Metabolism, and Abnormal Placental Pathology: a Multimodal Maternal-Fetal Study

NCT07565727 is registered in ClinicalTrials.gov with University of Tennessee Graduate School of Medicine as lead sponsor.

NCT NCT07565727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07565727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiometabolic Disease, Substrate Metabolism, and Abnormal Placental Pathology: a Multimodal Maternal-Fetal Study
Lead sponsor
University of Tennessee Graduate School of Medicine
Phase
Observational
Overall status
Recruiting
Start date
December 10, 2025
Completion date
August 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic diseases, gestational complications, gestational diabetes, gestational diabetes mellitus (gdm), gestational diabetes mellitus in pregnancy, insulin resistance, placental dysfunction, preeclampsia, preeclampsia (pe), preeclampsia (pe) risk, pregnancy, pregnancy complications